Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 16;6(5):186-195.
doi: 10.1093/jcag/gwad029. eCollection 2023 Oct.

Identification and Evaluation of Mobile Applications for Self-Management of Diet and Lifestyle for Patients with Inflammatory Bowel Disease

Affiliations

Identification and Evaluation of Mobile Applications for Self-Management of Diet and Lifestyle for Patients with Inflammatory Bowel Disease

Stephanie L Gold et al. J Can Assoc Gastroenterol. .

Abstract

Background: Mobile health applications (apps) providing diet and lifestyle self-management programs to patients with inflammatory bowel disease (IBD) are emerging. The objective of this study was to evaluate current apps available in the US and Canada based on app quality, perceived impact on diet and mental health and comprehensiveness to support self-management.

Methods: The Apple iOS and Google Play app stores were searched for terms related to IBD. Apps were included if they targeted diet and lifestyle behaviours for patients living with IBD and were available to the general public. Apps were excluded if they were not specific to IBD, not available in English, did not target diet or lifestyle therapy, were not available in the US and Canada, or did not offer stand-alone self-management programs. The Mobile App Rating Scale was used to assess mobile app quality.

Results: A total of 1,512 apps were identified through the app stores. Six apps met inclusion criteria. My IBD Care: Crohn's and Colitis received the highest quality rating and LyfeMD received the highest overall app rating. Only these two apps provided behaviour tracking over time, and three (50 percent) apps provided good-quality information.

Conclusions: While many IBD-related apps exist, few support self-management of diet and lifestyle behaviours. The My IBD Care and LyfeMD apps had the highest ratings and can be used to track lifestyle behaviours. The effectiveness of these apps to improve behaviours, and subsequently impact the disease course and quality of life, should be explored in future studies.

Keywords: MARS; inflammatory bowel disease; mobile applications; rating; self-management.

PubMed Disclaimer

Conflict of interest statement

CML was paid on contract for services provided to LyfeMD Inc. and is an employee in the research laboratory of one of the founders of LyfeMD Inc. VR was an employee in the research laboratory of one of the founders of LyfeMD Inc. and is currently an employee of LyfeMD Inc. SLG was supported by the Crohn’s and Colitis Foundation CRIA Career Development Award and member in the Medical Advisory Board, Nutrition Therapy for IBD Group.

Figures

Figure 1.
Figure 1.
The medical app identification and screening process is outlined here. Ultimately, 6 apps were included and the remainder were excluded for the reasons highlighted in the figure.

Similar articles

Cited by

References

    1. Dahlhamer JM, Zammitti EP, Ward BW, Wheaton AG, and Croft JB.. “Prevalence of Inflammatory Bowel Disease Among Adults Aged ≥18 years—United States, 2015.” MMWR Morbidity and Mortality Weekly Report 65, no. 42 (2016): 1166–69. - PubMed
    1. Kaplan GG, Bernstein CN, Coward S, Bitton A, Murthy SK, Nguyen GC, Lee Kate, Cooke-Lauder Jane, and Benchimol Eric I.. “The Impact Of Inflammatory Bowel Disease in Canada 2018: Epidemiology.” Journal of the Canadian Association of Gastroenterology 2, no. Suppl 1 (2019): S6–S16. 10.1093/jcag/gwy054. - DOI - PMC - PubMed
    1. Ananthakrishnan AN, Luo C, Yajnik V, Khalili H, Garber JJ, Stevens BW, Cleland T, and Xavier RJ.. “Gut Microbiome Function Predicts Response to Anti-Integrin Biologic Therapy in Inflammatory Bowel Diseases.” Cell Host and Microbe 21, no. 5 (2017): 603–610.e3. 10.1016/j.chom.2017.04.010. - DOI - PMC - PubMed
    1. Lee SH, Kwon JE, and Cho ML.. “Immunological Pathogenesis of Inflammatory Bowel Disease.” Intestinal Research 16, no. 1 (2018): 26–42. 10.5217/ir.2018.16.1.26. - DOI - PMC - PubMed
    1. Guan Q. “A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease.” Journal of Immunology Research 2019 (2019): 7247238. 10.1155/2019/7247238. - DOI - PMC - PubMed

LinkOut - more resources